BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33637645)

  • 1. Applications of Artificial Intelligence for Retinopathy of Prematurity Screening.
    Campbell JP; Singh P; Redd TK; Brown JM; Shah PK; Subramanian P; Rajan R; Valikodath N; Cole E; Ostmo S; Chan RVP; Venkatapathy N; Chiang MF; Kalpathy-Cramer J
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33637645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic Evaluation of Retinopathy of Prematurity Severity in a Large Telemedicine Program in India Using Artificial Intelligence.
    deCampos-Stairiker MA; Coyner AS; Gupta A; Oh M; Shah PK; Subramanian P; Venkatapathy N; Singh P; Kalpathy-Cramer J; Chiang MF; Chan RVP; Campbell JP
    Ophthalmology; 2023 Aug; 130(8):837-843. PubMed ID: 37030453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Smartphone-Based Telescreening for Retinopathy of Prematurity With and Without Artificial Intelligence in India.
    Young BK; Cole ED; Shah PK; Ostmo S; Subramaniam P; Venkatapathy N; Tsai ASH; Coyner AS; Gupta A; Singh P; Chiang MF; Kalpathy-Cramer J; Chan RVP; Campbell JP
    JAMA Ophthalmol; 2023 Jun; 141(6):582-588. PubMed ID: 37166816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of a Retinopathy of Prematurity Screening Model Using Artificial Intelligence in 3 Low- and Middle-Income Populations.
    Coyner AS; Oh MA; Shah PK; Singh P; Ostmo S; Valikodath NG; Cole E; Al-Khaled T; Bajimaya S; K C S; Chuluunbat T; Munkhuu B; Subramanian P; Venkatapathy N; Jonas KE; Hallak JA; Chan RVP; Chiang MF; Kalpathy-Cramer J; Campbell JP
    JAMA Ophthalmol; 2022 Aug; 140(8):791-798. PubMed ID: 35797036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
    Morrison SL; Dukhovny D; Chan RVP; Chiang MF; Campbell JP
    JAMA Ophthalmol; 2022 Apr; 140(4):401-409. PubMed ID: 35297945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinational External Validation of Autonomous Retinopathy of Prematurity Screening.
    Coyner AS; Murickan T; Oh MA; Young BK; Ostmo SR; Singh P; Chan RVP; Moshfeghi DM; Shah PK; Venkatapathy N; Chiang MF; Kalpathy-Cramer J; Campbell JP
    JAMA Ophthalmol; 2024 Apr; 142(4):327-335. PubMed ID: 38451496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.
    Ying GS; Quinn GE; Wade KC; Repka MX; Baumritter A; Daniel E;
    JAMA Ophthalmol; 2015 Mar; 133(3):304-11. PubMed ID: 25521746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.
    Daniel E; Ying GS; Siatkowski RM; Pan W; Smith E; Quinn GE;
    Ophthalmology; 2017 Mar; 124(3):374-381. PubMed ID: 27986386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics.
    Pivodic A; Hård AL; Löfqvist C; Smith LEH; Wu C; Bründer MC; Lagrèze WA; Stahl A; Holmström G; Albertsson-Wikland K; Johansson H; Nilsson S; Hellström A
    JAMA Ophthalmol; 2020 Jan; 138(1):21-29. PubMed ID: 31697330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.
    Ying GS; VanderVeen D; Daniel E; Quinn GE; Baumritter A;
    Ophthalmology; 2016 Oct; 123(10):2176-82. PubMed ID: 27491396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Examination Risk Prediction of Severe Retinopathy of Prematurity.
    Coyner AS; Chen JS; Singh P; Schelonka RL; Jordan BK; McEvoy CT; Anderson JE; Chan RVP; Sonmez K; Erdogmus D; Chiang MF; Kalpathy-Cramer J; Campbell JP
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity.
    Wade KC; Ying GS; Baumritter A; Gong A; Kemper AR; Quinn GE;
    JAMA Ophthalmol; 2019 Feb; 137(2):160-166. PubMed ID: 30452500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVALUATION OF ARTIFICIAL INTELLIGENCE-BASED QUANTITATIVE ANALYSIS TO IDENTIFY CLINICALLY SIGNIFICANT SEVERE RETINOPATHY OF PREMATURITY.
    Li J; Huang K; Ju R; Chen Y; Li M; Yang S; Wang Y; Dong W; Liu M; Chen S; Leng H; Zhong J
    Retina; 2022 Jan; 42(1):195-203. PubMed ID: 34387234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy of prematurity screening criteria in Iran: new screening guidelines.
    Roohipoor R; Karkhaneh R; Farahani A; Ebrahimiadib N; Modjtahedi B; Fotouhi A; Yaseri M; Khodabande A; Zarei M; Imani Fuladi M; Taheri A; Riazi Esfahani M; Loewenstein J
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F288-93. PubMed ID: 27073259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Artificial Intelligence System for Retinopathy of Prematurity Screening in Nepal and Mongolia.
    Cole E; Valikodath NG; Al-Khaled T; Bajimaya S; Kc S; Chuluunbat T; Munkhuu B; Jonas KE; Chuluunkhuu C; MacKeen LD; Yap V; Hallak J; Ostmo S; Wu WC; Coyner AS; Singh P; Kalpathy-Cramer J; Chiang MF; Campbell JP; Chan RVP
    Ophthalmol Sci; 2022 Dec; 2(4):100165. PubMed ID: 36531583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of treatment-warranted retinopathy of prematurity in the SUNDROP cohort: influence of photographic features.
    Ludwig CA; Greven MA; Moshfeghi DM
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1935-1946. PubMed ID: 28782073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of artificial intelligence-based telemedicine screening for retinopathy of prematurity.
    Greenwald MF; Danford ID; Shahrawat M; Ostmo S; Brown J; Kalpathy-Cramer J; Bradshaw K; Schelonka R; Cohen HS; Chan RVP; Chiang MF; Campbell JP
    J AAPOS; 2020 Jun; 24(3):160-162. PubMed ID: 32289490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Deep Learning Model to Predict the Occurrence and Severity of Retinopathy of Prematurity.
    Wu Q; Hu Y; Mo Z; Wu R; Zhang X; Yang Y; Liu B; Xiao Y; Zeng X; Lin Z; Fang Y; Wang Y; Lu X; Song Y; Ng WWY; Feng S; Yu H
    JAMA Netw Open; 2022 Jun; 5(6):e2217447. PubMed ID: 35708686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plus Disease in Telemedicine Approaches to Evaluating Acute-Phase ROP (e-ROP) Study: Characteristics, Predictors, and Accuracy of Image Grading.
    Cheng QE; Daniel E; Pan W; Baumritter A; Quinn GE; Ying GS;
    Ophthalmology; 2019 Jun; 126(6):868-875. PubMed ID: 30690127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks.
    Brown JM; Campbell JP; Beers A; Chang K; Ostmo S; Chan RVP; Dy J; Erdogmus D; Ioannidis S; Kalpathy-Cramer J; Chiang MF;
    JAMA Ophthalmol; 2018 Jul; 136(7):803-810. PubMed ID: 29801159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.